SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 26th, 2023 • Acasti Pharma Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 26th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 24, 2023, between Acasti Pharma Inc., a corporation incorporated under the Business Corporations Act (Québec) (formerly Part 1A of the Companies Act (Québec)) and domiciled in Canada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 1st, 2021 • Enveric Biosciences, Inc. • Semiconductors & related devices • New York
Contract Type FiledApril 1st, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 10, 2020, between Jay Pharma, Inc., a Canadian corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 26th, 2021 • Mitesco, Inc. • Finance services • Delaware
Contract Type FiledMarch 26th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 25, 2021, between Mitesco, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 3rd, 2019 • Reign Sapphire Corp • Retail-jewelry stores • New York
Contract Type FiledOctober 3rd, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 29, 2019, between Reign Sapphire Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 15th, 2019 • Sylios Corp • Crude petroleum & natural gas • Nevada
Contract Type FiledMay 15th, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 2, 2019, between Sylios Corp., a Florida corporation and its predecessors (the “Company”), and each purchaser identified on Schedule I and in accordance with the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 12th, 2019 • IIOT-OXYS, Inc. • Services-prepackaged software • New York
Contract Type FiledMarch 12th, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of ____________________, 2019, between IIOT-OXYS, INC., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 5th, 2019 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 5th, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 19, 2019, between Creative Medical Technology Holdings, Inc., a Nevada corporation and its predecessors (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 23rd, 2018 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 23rd, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 15, 2018, between Creative Medical Technology Holdings, Inc., a Nevada corporation and its predecessors (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 10th, 2018 • Integrated Ventures, Inc. • Retail-miscellaneous retail • New York
Contract Type FiledOctober 10th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 21, 2018, between Integrated Ventures, Inc., a Nevada corporation and its predecessors (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 10th, 2018 • Integrated Ventures, Inc. • Retail-miscellaneous retail • New York
Contract Type FiledOctober 10th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 21, 2018, between Integrated Ventures, Inc., a Nevada corporation and its predecessors (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2018 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 27th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 13, 2018, between Creative Medical Technology Holdings, Inc., a Nevada corporation and its predecessors (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 17th, 2018 • Genius Brands International, Inc. • Services-motion picture & video tape production • New York
Contract Type FiledAugust 17th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 17, 2018, between Genius Brands International, Inc., a Nevada corporation and includes any successor Company thereto (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 9th, 2018 • MaxQ AI Ltd. • Services-computer programming services • New York
Contract Type FiledAugust 9th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 29, 2017, between MedyMatch Technology Ltd., a company incorporated under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 15th, 2018 • PV Nano Cell, Ltd. • Miscellaneous chemical products • New York
Contract Type FiledMay 15th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of _______ ___, 2017, between P.V. Nano Cell Ltd., a corporation formed under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 26th, 2018 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJanuary 26th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January __, 2018, among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 20th, 2017 • Greater Cannabis Company, Inc. • Delaware
Contract Type FiledJune 20th, 2017 Company JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 25, 2017, between The Greater Cannabis Company, Inc., a Florida corporation and its predecessors (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 11th, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 11th, 2016 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 23, 2014, between Accelerated Pharma, Inc., a Delaware corporation (the “Company”). and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 16th, 2016 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledFebruary 16th, 2016 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 11, 2016, between Guided Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 24th, 2015 • 2304101 Ontario Inc. • New York
Contract Type FiledSeptember 24th, 2015 Company JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 7, 2015, between 2304101 Ontario Inc. (operating as Behavioural Neurological Applications and Solutions), an Ontario corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 27th, 2006 • Aprecia Inc • Services-prepackaged software • New York
Contract Type FiledDecember 27th, 2006 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 10, 2006 among Aprecia Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).